TSTong Sun

Tong Sun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tong Sun has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of the first open-access hepatitis B and safe injection online training course for health professionals in China

    by Jing Wang, Qiming Feng, Andrew Tam, Tong Sun, Peijing Zhou, Samuel So

    Despite the high prevalence of chronic hepatitis B virus (HBV) infection in China, HBV infection prevention and long-term care knowledge of health professionals is inadequate. To address this knowledge gap, we developed an open-access evidence-based online training course,


    • 1 August 2015
      • Vol. 36  (8) , 815-20

    [Study on smoking status in families and its influence on children in Shandong province].

    by Xia Wei, Peijing Zhou, Fengxia Li, Renyou Chen, Dianmin Kang, Ting Liu, Tong Sun

    To study the smoking status and influence of the families on pupils regarding smoking-related knowledge, attitudes and behavior, in Shandong province. A multi-stage stratified-cluster random sampling method was used to investigate 6 050 students and their families in 3 different cities. A self-administered anonymous questionnaire survey was conducted by trained investigators. The overall passive smoking rate at households of the pupils was 49.7% in Shandong province and appeared the highest in separate families, followed by in re-organized families and multiple-generation families under the same roofs. Major smokers in the families were fathers and grandfathers, with 43.4% of the fathers and 74.0% of the grandfathers had smoking histories for more than 10 years. The main smoking places at home were "elsewhere" or in the "living room". Attempting and current smoking rates of the families were 7.7% and 1.7% respectively, significantly higher than those families with no smokers. There was significant difference in smoking associated behavior and attitude between pupils whose family members with smoking habits or without. The status of smoking in the families of the pupil's family was not optimistic in Shandong province, especially in the families of the male students. Since smoking status of the families played an important role on their children, it is necessary to explore suitable health education model to improve the smoking associated behaviors in the families.

    • 1 November 2013
      • Vol. 34  (11) , 1091-5

    [Prevalence and related risk factors on smoking among pupils in Shandong province].

    by Xia Wei, Tong Sun, Pei-Jing Zhou, Ren-You Chen, Dian-Min Kang

    To study the prevalence of smoking and its influential factors among pupils in Shandong. A multi-stage stratified-cluster random sampling method was used in the survey. 6050 students from 3 different cities of Shandong province were selected as the study population. A self-administered anonymous questionnaire was designed and the survey was conducted by trained investigators. The rate of attempting smoking among pupils under study in Shandong province was 6.0% while the current smoking rate was 1.2%. The average age of children who initiated smoking cigarette was 7.8±2.1 with 80.5% of them due to curiosity. 34.7% of them got the cigarettes from their families. In terms of the motivation of buying cigarettes, 74.3% of them claimed that the access to purchase was easy. Data from multivariate unconditional logistic regression analysis showed that the smoking behavior of pupils was influenced by their familial or surrounding environments. Tobacco control programs on pupils should be strengthened with more powerful control measures including health education.


    • 1 August 2013
      • Vol. 35  (8) , 618-22

    [Efficacy and safety of rh-endostatin combined with docetaxel in second-line or intolerant toxicity for first-line treatment in patients with advanced non-small cell lung cancer].

    by Jing Wang, Kai Li, Tong Sun, Ming-Jun Zhang, Wei-Lian Li, Qiang Yao, Wei Liu, Cui-Min Ding, Zhi-Yong He, Wei-Dong Mao, et al.

    To analyze the efficacy and safety of combination of rh-endostatin (Endostar) with docetaxel treatment on patients of non-small cell lung cancer (NSCLC) who presented PD or intolerable toxicity in/after first-line chemotherapy. A randomized, double-blind, placebo-controlled and multi-center clinical trial was conducted. Patients with stage IIIB/IV of NSCLC experienced previous chemotherapy of one-regimen were screened for this trial. A total of 68 cases were included in this study. Single docetaxel and that combined with endostar were conducted in two arms. The response, time to progression (TTP) and adverse effects were observed in both arms. The objective response rate (ORR) and clinical benefit rate (CBR) were 0 and 62.5% in the combined arm, along with 0 and 53.3% in the single docetaxel arm, with a non-significant difference between the two groups (all P > 0.05), respectively. The median TTPs in the combined and single docetaxel arms were 2.63 and 2.07 months, respectively (P = 0.079). The median TTPs of the participants with progressive disease (PD) after first-line chemotherapy were 1.33 and 1.67 months in the combined and single docetaxel arms, respectively (P = 0.946). The median TTPs of the participants with intolerant adverse effects in first-line chemotherapy were 4.70 months and 3.17 months in the combined and single docetaxel arms, respectively (P = 0.070). The median TTPs of the patients with SD after 2 therapeutic cycles in the combined and single docetaxel arms were 6.23 months and 3.27 months, respectively (P = 0.040). The differences between two arms were non-significant in adverse, serious adverse and cardiovascular adverse effects (all P > 0.05). Endostar may prolong TTP in patients with advanced NSCLC benefited from docetaxel treatment without increased toxicities.